Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catheter Precision, Inc. Common Stock (NY: VTAK )

0.3868 +0.0118 (+3.15%)
Official Closing Price Updated: 8:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catheter Precision, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American:VTAK) Reports First Purchase Order for LockeT in a New US Territory
Via ACCESSWIRE
Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Catheter Precision, Inc. (NYSE American: VTAK) Reports Preliminary Unaudited Revenue for the Second Quarter and Six Months Ended June 30, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Falls 1%; MongoDB Shares Spike Higher
Via Benzinga
Crude Oil Down Over 2%; US Core PCE Prices Rise 0.2% In July
Via Benzinga
Exposures Fossil Fuels
Nasdaq Jumps Over 100 Points; Dell Posts Upbeat Results
Via Benzinga
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering
Via ACCESSWIRE
VTAK Stock Earnings: Catheter Precision, Inc. Common Stock Reported Results for Q2 2024
Catheter Precision, Inc. Common Stock just reported results for the second quarter of 2024. 
Via InvestorPlace
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q2 2024 Highlights and Operational Performance Report
Via ACCESSWIRE
Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology
Via ACCESSWIRE
LargeCap Big Tech Stocks Report Earnings Today: Discover SmallCap Stocks Inside to Watch Now!
Via AB Newswire
Catheter Precision, Inc. Completes Enrollment of 75 Patients in LockeT-II Study
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with! 
Via InvestorPlace
5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
Via AB Newswire
Exposures Product Safety
Catheter Precision Inc. (NYSE American: VTAK) Moves Forward with Aggressive Expansion Strategy and New Share Structure
Via AB Newswire
Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO
Via ACCESSWIRE
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
Via Benzinga
Exposures Fossil Fuels
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
Via Benzinga
Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split
Via ACCESSWIRE
Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
Via AB Newswire
Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS
Via AB Newswire
July 2024 Hot Small-Cap Stocks Under $5 Gaining Now: KAVL, VTAK, INBS, BSFC, PRSO
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Stock Volume Soars with Middle East Expansion of VIVO 3D Heart Imaging System
Via AB Newswire
Catheter Precision, Inc. Announces Receipt of First Purchase Order for VIVO from Distributor in Middle East
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.